Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

4.8K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.8K
Gene Evolution - Fast or Slow?02:05

Gene Evolution - Fast or Slow?

7.0K
The genomes of eukaryotes are punctuated by long stretches of sequence which do not code for proteins or RNAs. Although some of these regions do contain crucial regulatory sequences, the vast majority of this DNA serves no known function. Typically, these regions of the genome are the ones in which the fastest change, in evolutionary terms, is observed, because there is typically little to no selection pressure acting on these regions to preserve their sequences.
In contrast, regions which code...
7.0K
Incomplete Dominance01:43

Incomplete Dominance

20.6K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
20.6K
Pleiotropy01:33

Pleiotropy

38.9K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
38.9K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

12.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.3K
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

16.9K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
16.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

KG-Microbe - Building Modular and Scalable Knowledge Graphs for Microbiome and Microbial Sciences.

GigaScience·2026
Same author

A pragmatist approach to bridging tables and ontologies through LinkML and punning.

Journal of biomedical semantics·2026
Same author

A layered standards framework for integrating single-cell and spatial omics data into brain cell atlases.

bioRxiv : the preprint server for biology·2026
Same author

VO: The Vaccine Ontology.

Scientific data·2026
Same author

The Cell Ontology in the age of single-cell omics.

Scientific data·2026
Same author

Blood-based RNA-Seq of 5412 individuals with rare disease identifies new candidate diagnoses in the National Genomic Research Library.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: May 21, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
00:06

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.6K

Towards a standard benchmark for phenotype-driven variant and gene prioritisation algorithms: PhEval - Phenotypic

Yasemin Bridges1, Vinicius de Souza2, Katherina G Cortes3

  • 1William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6BQ, UK. y.bridges@qmul.ac.uk.

BMC Bioinformatics
|March 23, 2025
PubMed
Summary

PhEval is a new tool that provides a standardized framework for evaluating variant and gene prioritization algorithms (VGPAs) used in rare disease diagnosis. It enables reproducible benchmarking using real-world patient data, improving diagnostic accuracy.

Keywords:
Benchmarking FrameworkBioinformaticsPhenopacketsPhenotype-driven analysisRare disease diagnosisVariant prioritisation

More Related Videos

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

9.6K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.1K

Related Experiment Videos

Last Updated: May 21, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
00:06

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.6K
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

9.6K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.1K

Area of Science:

  • Genomics
  • Bioinformatics
  • Computational Biology

Background:

  • Rare disease diagnosis relies on complex computational tools like variant and gene prioritization algorithms (VGPAs).
  • Evaluating the performance of VGPAs is challenging due to data integration complexities and lack of standardized benchmarking frameworks.
  • Current limitations hinder the development and reliability of VGPAs, impacting rare disease diagnostic pipelines.

Purpose of the Study:

  • To introduce PhEval, a novel benchmarking tool designed to standardize the evaluation of phenotype-driven VGPAs.
  • To provide a reproducible and empirical framework for assessing VGPA performance in rare disease diagnosis.

Main Methods:

  • PhEval incorporates standardized test corpora and generation tools for open benchmarking.
  • The framework utilizes real-world patient data from case reports for cohort standardization.
  • It controls the configuration of evaluated VGPAs to ensure consistent testing.

Main Results:

  • PhEval establishes a standardized, empirical framework for evaluating VGPAs.
  • The tool addresses limitations in patient data availability and experimental setup for benchmarking.
  • Open benchmarking and comparison of VGPAs are facilitated through standardized datasets.

Conclusions:

  • PhEval enhances the transparency, portability, comparability, and reproducibility of VGPA benchmarking.
  • By standardizing assessment, PhEval is crucial for improving rare disease diagnosis and patient care.
  • The tool supports the development of more effective VGPAs, a key component in diagnostic pipelines.